Sun W et al. |
Synergistic drug combination effectively blocks Ebola virus infection. |
2017 |
Antiviral Res. |
pmid:27890675
|
Sato T et al. |
In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21220530
|
Nilius AM et al. |
Comparative in vitro activity of ABT-773, a novel antibacterial ketolide. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11408246
|
Lounis N et al. |
ATP synthase inhibition of Mycobacterium avium is not bactericidal. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19738016
|
Hamasuna R et al. |
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19738019
|
Comley JC and Sterling AM |
Effect of atovaquone and atovaquone drug combinations on prophylaxis of Pneumocystis carinii pneumonia in SCID mice. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7785975
|
Odenholt-Tornqvist I et al. |
Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7695310
|
Struillou L et al. |
Activities of roxithromycin against Mycobacterium avium infections in human macrophages and C57BL/6 mice. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7785988
|
Rodvold KA et al. |
Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9174209
|
Ishida K et al. |
In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031048
|
Bax HI et al. |
Tigecycline Potentiates Clarithromycin Activity against Mycobacterium avium In Vitro. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26883697
|
Aziz DB et al. |
Rifabutin Is Active against Mycobacterium abscessus Complex. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28396540
|
Xu YF et al. |
and Antibacterial Activities of Patchouli Alcohol, a Naturally Occurring Tricyclic Sesquiterpene, against Helicobacter pylori Infection. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28320722
|
Geng X et al. |
The Bifunctional Enzyme SpoT Is Involved in the Clarithromycin Tolerance of Helicobacter pylori by Upregulating the Transporters HP0939, HP1017, HP0497, and HP0471. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28242673
|
Waites KB et al. |
In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2973283
|
Yasuda H et al. |
Interaction between clarithromycin and biofilms formed by Staphylococcus epidermidis. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8141568
|
Fujii K et al. |
In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8067748
|
Tomioka H et al. |
Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10582897
|
Pankuch GA et al. |
MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878583
|
Chang HR and Pechère JC |
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2837140
|
Romand S et al. |
In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285620
|
Alder J et al. |
Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8328782
|
Kosowska-Shick K et al. |
Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agents. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17116666
|
Kim IS et al. |
Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17116681
|
Morikawa K et al. |
Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7532933
|
Ednie LM et al. |
Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843313
|
Goldman RC et al. |
Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979278
|
Roblin PM et al. |
Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979292
|
Bui KQ et al. |
Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10471584
|
Inderlied CB et al. |
Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986017
|
Gorzynski EA et al. |
Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2524998
|
Cynamon MH and Klemens SP |
Activity of azithromycin against Mycobacterium avium infection in beige mice. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329622
|
Bermudez LE et al. |
Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986018
|
Khan AA et al. |
Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9145840
|
Collins L and Franzblau SG |
Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9145860
|
Lounis N et al. |
Comparative activities of amikacin against Mycobacterium avium complex in nude and beige mice. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9145892
|
Fernandes PB et al. |
New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolide-lincosamide-streptogramin B resistance. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2523688
|
Tateda K et al. |
Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891128
|
Kanamaru T et al. |
In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11502514
|
Fernandes PB et al. |
In vitro and in vivo activities of clarithromycin against Mycobacterium avium. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2530933
|
Alvarez A et al. |
Antimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori isolates from patients in the western central region of Colombia. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19546360
|
Koh WJ et al. |
Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23478956
|
Kohno Y et al. |
Comparative pharmacokinetics of clarithromycin (TE-031), a new macrolide antibiotic, and erythromycin in rats. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2526615
|
Rimbara E et al. |
Novel mutation in 23S rRNA that confers low-level resistance to clarithromycin in Helicobacter pylori. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18606842
|
Jesus FP et al. |
In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25001300
|
Khan R et al. |
T2182C mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15328128
|
Johnson MM et al. |
Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428903
|
Walzer PD et al. |
Clinically used antimicrobial drugs against experimental pneumocystosis, singly and in combination: analysis of drug interactions and efficacies. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9021174
|
Credito KL et al. |
Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428930
|
Banerjee DK et al. |
Experimental evaluation of possible new short-term drug regimens for treatment of multibacillary leprosy. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9021187
|
Klopman G et al. |
Anti-Mycobacterium avium activity of quinolones: in vitro activities. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239587
|
Bermudez LE et al. |
Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7695252
|
Mor N et al. |
Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7695255
|
Lacassin F et al. |
Clarithromycin-minocycline combination as salvage therapy for toxoplasmosis in patients infected with human immunodeficiency virus. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7695324
|
Hotomi M et al. |
Genetic characteristics and clonal dissemination of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains isolated from the upper respiratory tract of patients in Japan. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17698631
|
Nagai K et al. |
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11600391
|
Klemens SP and Cynamon MH |
Intermittent azithromycin for treatment of Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986001
|
Brown BA et al. |
Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1317144
|
Stone GG et al. |
A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9056021
|
Friedman ND et al. |
Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26883709
|
Bastian S et al. |
Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21135185
|
Tessier PR et al. |
Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia. |
2002 |
Antimicrob. Agents Chemother. |
pmid:11959578
|
Ichiyama T et al. |
Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11120942
|
Heifets L et al. |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8031351
|
Wolinsky E |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031406
|
Mathis A et al. |
Mitochondrial ribosome as the target for the macrolide antibiotic clarithromycin in the helminth Echinococcus multilocularis. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16048933
|
Dai G et al. |
Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16048962
|
Bermudez LE et al. |
Identification of (+)-erythro-mefloquine as an active enantiomer with greater efficacy than mefloquine against Mycobacterium avium infection in mice. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22615290
|
Cynamon MH et al. |
Comparative activities of azithromycin and clarithromycin against Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979270
|
Anton E et al. |
Randomized Trial of Clarithromycin for Mediterranean Spotted Fever. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26711765
|
Klemens SP and Cynamon MH |
Activities of azithromycin and clarithromycin against nontuberculous mycobacteria in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979271
|
Vaara M et al. |
A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20479195
|
Bermudez LE et al. |
Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10991834
|
Wang G et al. |
Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11181351
|
Rastogi N et al. |
In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10991870
|
Ishikawa C et al. |
Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19258275
|
Araujo FG et al. |
Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489188
|
Gan VN et al. |
Pharmacokinetics of a clarithromycin suspension in infants and children. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489191
|
Ji B et al. |
Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482155
|
Rastogi N and Goh KS |
Effect of pH on radiometric MICs of clarithromycin against 18 species of mycobacteria. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482156
|
Rastogi N et al. |
Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482157
|
Prazeres Magalhães P et al. |
Helicobacter pylori primary resistance to metronidazole and clarithromycin in Brazil. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12019131
|
Mor N and Esfandiari A |
Synergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophages. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303411
|
Alder JD et al. |
Dynamics of clarithromycin and azithromycin efficacies against experimental Haemophilus influenzae pulmonary infection. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9736568
|
Kishii K et al. |
In vitro activity of tebipenem, a new oral carbapenem antibiotic, against beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20585130
|
Polis MA et al. |
Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infection. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9257746
|
Bernut A et al. |
In vivo assessment of drug efficacy against Mycobacterium abscessus using the embryonic zebrafish test system. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24798271
|
Spyridaki I et al. |
Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19332671
|
Lounis N et al. |
Efficacies of clarithromycin regimens against Mycobacterium xenopi in mice. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11600387
|
Weiss S et al. |
Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26392505
|
Gikas A et al. |
In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11600400
|
Parra-Ruiz J et al. |
Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20696880
|
Wenisch C et al. |
Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878577
|
Lounis N et al. |
Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793860
|
Donati M et al. |
In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20855744
|
Fattorini L et al. |
In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793873
|
Cohen Y et al. |
Use of normal C57BL/6 mice with established Mycobacterium avium infections as an alternative model for evaluation of antibiotic activity. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793882
|
Furney SK et al. |
Activities of rifabutin, clarithromycin, and ethambutol against two virulent strains of Mycobacterium avium in a mouse model. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793895
|
Piccolomini R et al. |
Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9797240
|
Patel KB et al. |
Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891147
|